Pay in 4 interest-free payments of $7.02 Learn more
Ships within 48 hours · Estimated delivery Aug 8 - Aug 13
patients must meet qualifying criteria set through negotiations This is the largest potential expansion of obesity drug access in Medicaid history but its not automatic
Sanamiri K et al
250 mcg 7.5 units and 500 mcg = 15 units on a U-100 syringe
doi: 10.1002/cpdd.70001
This makes it a versatile solution for those looking to reduce fat in specific areas of their body
[Ref] Other Very common (10% or more): Pain (35%), flu syndrome (29%), chest pain (15%), accidental injury (12%), asthenia (12%), fever (12%) Common (1% to 10%): Peripheral edema, weight decrease, weight increase Very rare (less than 0.01%): Body odor, International Normalized Ratio (INR) increased [Ref] Local Very common (10% or more): Injection site reaction (38%) [Ref] Musculoskeletal Musculoskeletal side effects, in chronic hemodialysis patients, for levocarnitine (the active ingredient contained in L-Carnitine) in relation to placebo therapy have included asthenia (8% to 12% vs 8%) and leg cramps (4% to 8% vs 13%)
US$ 26.82
US$ 22.79
US$ 29.31
US$ 27.94
US$ 28.62
